"/> Invitrogen™ Kit ELISA BID de souris | B-LABO France

Invitrogen™ Kit ELISA BID de souris

Réf. : BL-RE-094020Réf. fabricant : 18517814 10 x 96 Tests
Prix sur devis
Tarif personnalisé selon la configuration et la quantité.

Mouse BID quantitates mouse BID in serum, plasma, supernatant.

Numéro d’adhésion
2700049M22Rik; AI875481; apoptic d; apoptic death agonist; apoptotic death agonist BID; AU022477; BH3 interacting domain death agonist; BH3-interacting domain death agonist; BH3-interacting domain death agonist p11; BH3-interacting domain death agonist p13; BH3-interacting domain death agonist p15; Bid; BID isoform ES(1 b); BID isoform L(2); BID isoform Si6; desmocollin type 4; FP497; HGNC:1050; Human BID coding sequence; MGC15319; MGC42355; OTTHUMP00000196197; p11 BID; p13 BID; p15 BID; p22 BID
Plage de dosage
0.41 to 100 ng/mL
Sensibilité du dosage
0.41 ng/mL
Conjugué
Biotin
Type de produit
ELISA
Marque
Invitrogen

BID is a death agonist that heterodimerizes with either agonist BAX or antagonist BCL2. Bid is a member of the BCL-2 family of cell death regulators. BID is a mediator of mitochondrial damage induced by caspase-8 (CASP8); CASP8 cleaves this encoded protein, and the COOH-terminal part translocates to mitochondria where it triggers cytochrome c release. BID is also a pro-apoptotic member of the Bcl 2 family. BID usually exists in an inactive form in the cytosolic fraction of living cells and becomes cleaved and activated by caspase 8 in response to TNF alpha or Fas ligand. Once BID is cleaved, the C-terminal 15 kDa fragment of BID (p15) translocates onto mitochondria and is sufficient to trigger cytochrome c release, resulting in cell apoptosis. BID serves as a direct molecular link between caspase 8 activation and mitochondrial death machinery.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-094020
Réf. fabricant18517814
Numéro d’adhésion2700049M22Rik; AI875481; apoptic d; apoptic death agonist; apoptotic death agonist BID; AU022477; BH3 interacting domain death agonist; BH3-interacting domain death agonist; BH3-interacting domain death agonist p11; BH3-interacting domain death agonist p13; BH3-interacting domain death agonist p15; Bid; BID isoform ES(1 b); BID isoform L(2); BID isoform Si6; desmocollin type 4; FP497; HGNC:1050; Human BID coding sequence; MGC15319; MGC42355; OTTHUMP00000196197; p11 BID; p13 BID; p15 BID; p22 BID
Plage de dosage0.41 to 100 ng/mL
Sensibilité du dosage0.41 ng/mL
ConjuguéBiotin
Type de produitELISA
Type d’échantillonSerum
À utiliser avec (équipement)Colorimetric Microplate Reader
Identification génétique (Entrez)P70444
Symbole de gène(s)BID
Coefficient de variation inter-dosage<12%
Coefficient de variation intra-dosage<10%
Contenus des kitsPre-coated 96 well plate, Standard, Assay Diluent concentrate, Biotinylated Detection Antibody, SAV-HRP, Wash Buffer, Chromogen, Stop Solution, Adhesive Plate Covers
Marqueur ou colorantHRP
Quantité10 x 96 Tests
État réglementaireResearch Use Only
Volume d’échantillonSerum, 50 µL; Plasma, 50 µL; Supernatant, 50 µL
Conditions de stockage2°C to 8°C
CibleBID
Heure du test1 hr 20 min
Durée totale du dosage4 hr 45 min
Une question, une configuration particulière ?
Contactez-nous pour un devis.